Choose Your Country or Region
Australia
Austria
Belgium
Brazil
Canada
China
Czech Republic
Denmark
Finland
France
Germany
Greece
Hong Kong
Hungary
Iceland
India
Ireland
Israel
Italy
Japan
Korea
Luxembourg
Malaysia
Netherlands
New Zealand
Norway
Poland
Qatar
Romania
Saudi Arabia
Singapore
Spain
Sweden
Switzerland
Taiwan
Turkey
United Kingdom
United States
| Catalog No. | Product Name | Information |
|---|---|---|
| S6982 | 3CAI | 3CAI inhibits AKT1 and AKT2. |
| E5971 | ZINC00640089 | ZINC00640089 is a selective Lipocalin-2 (LCN2) inhibitor that suppresses cell proliferation, decreases cell viability, and reduces AKT phosphorylation levels in SUM149 cells. This compound shows promising research potential for inflammatory breast cancer (IBC) studies. |
| F4087 | Phospho-Akt1 (Ser473) Antibody [K10L8] | |
| ≡ All Akt Inhibitors | ||
Products are for research use only. Not for human use. We do not sell to patients.
©Copyright 2013 Selleck Chemicals. All Rights Reserved.